Last updated 3 months ago

AxellaCoin: MVP for Decentralized Biotech Trial Funding

Problem

Clinical trials for rare or early-stage therapies struggle with funding access. Traditional financing is centralized, slow, and often excludes smaller biotech innovators.

Solution

Build a Cardano-based MVP to fund biotech trials with milestone payments, staking-to-support, and NFT badges, enabling real-world clinical research via smart contracts.

Total to date

This is the total amount allocated to AxellaCoin: MVP for Decentralized Biotech Trial Funding.

₳95,000
Total funds requested
84
Total votes cast
₳7.69M
Votes yes
₳6.52M
Votes abstain

About this idea

Team

Avi Kamelhar – Founder of AxellaCoin and CEO of Axella Research, with 15+ years in clinical trial operations and biotech startup partnerships. Leads strategy, trial partner engagement, and oversight.

Dr. Judd Boczko – Scientific advisor specializing in data science and clinical analytics. Supports real-world use-case validation and research integration.

CTO (To Be Hired) – A Plutus/Aiken smart contract developer from the Cardano ecosystem will be recruited to build and launch the MVP.

Additional advisors include experts in tokenomics, regulatory affairs, and blockchain compliance.